Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Stockholder-Equity" stands at -156.73 Billion Japanese Yens as of 06/30/2025.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Other Stockholder Equity" stands at -156.73 Billion JPY. This represents a decrease of -6.39 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -77.13 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -77.13 Billion Japanese Yens.
The 3 year change is -119.33 Billion Japanese Yens.
The 5 year change is -89.95 Billion Japanese Yens.
The 10 year change is -121.72 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Stockholder Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Stockholder Equity | 280,205,508,085.11 |